These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9890408)

  • 1. Analysis of arrhythmias in the Circadian Antiischemia Program in Europe (CAPE) study.
    Lichtlen PR; Fisher LD
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):135-9. PubMed ID: 9890408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).
    Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E
    J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
    Deanfield JE
    Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators.
    Madjlessi-Simon T; Fillette F; Mary-Krause M; Lechat P; Jaillon P
    Eur Heart J; 1995 Dec; 16(12):1780-8. PubMed ID: 8682007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine and the total ischemic burden: circadian anti-ischemia program in Europe (CAPE) trial-methodology, safety and toleration. The Steering Committee members and all of the investigators.
    Detry JM
    Cardiology; 1994; 85 Suppl 2():24-30. PubMed ID: 7736484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
    J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.
    Udelson JE; DeAbate CA; Berk M; Neuberg G; Packer M; Vijay NK; Gorwitt J; Smith WB; Kukin ML; LeJemtel T; Levine TB; Konstam MA
    Am Heart J; 2000 Mar; 139(3):503-10. PubMed ID: 10689266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group.
    Chahine RA; Feldman RL; Giles TD; Nicod P; Raizner AE; Weiss RJ; Vanov SK
    J Am Coll Cardiol; 1993 May; 21(6):1365-70. PubMed ID: 8166777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis.
    Bird GL; Prach AT; McMahon AD; Forrest JA; Mills PR; Danesh BJ
    J Hepatol; 1998 Feb; 28(2):194-8. PubMed ID: 9514531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients.
    Mroczek WJ; Burris JF; Allenby KS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S13-5. PubMed ID: 16296699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine reduces myocardial ischaemia during exercise without compromising left ventricular function in patients with silent ischaemia: a randomised, double-blind, placebo-controlled study.
    Bech J; Madsen JK; Kelbaek H
    Eur J Heart Fail; 1999 Dec; 1(4):395-400. PubMed ID: 10937953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
    Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
    Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.